IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats

Conclusion: The blocking of the signaling of these proinflammatory molecules is able to reduce HIV-related neuropathic pain, which provide a novel mechanism-based approach to treating HIV-associated neuropathic pain using gene therapy

http://www.molecularpain.com/content/10/1/49

Source: Molecular Pain - July 30, 2014 Category: Molecular Biology Authors: Wenwen ZhengWan HuangShue LiuRoy LevittKeith CandiottiDavid LubarskyShuanglin Hao Source Type: research